Central Nervous System Prophylaxis and Treatmen...
Frontiers | Predicting pathological complete re...
IJMS | Free Full-Text | Enhanced Chemosensitivi...
Do cancer cells die because of Nogo-B? | Oncogene
Risk group, therapy, and second malignant neopl...
Oncology Brothers on Twitter: "Neoadj Nivolumab...
Enhanced Chemosensitivity by Targeting Nanog in...
Knockout of the Nogo-B Gene Attenuates Tumor Gr...
NSSG Chemotherapy Protocol / nssg-chemotherapy-...
Activation of hepatic Nogo-B receptor expressio...
Thromboembolism in acute lymphoblastic leukemia...
Nogo‑B receptor in relevant carcinoma: Current ...
20220611020649 - New
Nogo-B receptor increases the resistance to tam...
Nogo-B Promotes Angiogenesis And Improves Cardi...
Frontiers | Upfront Treatment of Pediatric High...
Overview of the NOPHO 92 Protocol | Download Table
Nogo‐B receptor is necessary for cellular dolic...
Making an Informed Treatment Choice for Aggress...
Long-term results of NOPHO ALL-92 and ALL-2000 ...
Frontiers | The safety of neoadjuvant chemother...
Nogo-B regulates endothelial sphingolipid homeo...